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Materials and Methods
Molecular biology and transient expression. Human, rat, dog, guinea pig and chicken TRPA1
were cloned in pcDNA3.1 Hygro vector. Human-rat TRPA1 chimeras were generated by PCR or DNA synthesis, and mutations were generated by using QuikChange Site-directed mutagenesis kit (Stratagene) as reported previously (1). Transient expression in HEK293-F cells was performed using FreeStyle293 Expression System (Invitrogen). All wild type channels, chimeras and mutants were characterized by at least two independent transfections.
Calcium influx assays and electrophysiological recordings. The calcium influx assay was performed as reported previously (1). A 384 -well format Ca 2+ assay was developed using a FDSS/µCell Image Plate Reader (Hanamatsu) and Calcium assay kit (BD#640178). 48 hours after transient transfection, cells were loaded with calcium dye, and a double addition protocol was used: test compound was added, followed by a second addition with AITC. Agonist activity is defined as the ability of eliciting Ca 2+ response, and antagonist activity is defined as the ability of 
Homology Modeling
Closed TRPA1 (Refined) : We used the cryo-EM structure of human TRPA1 (3j9p.pdb) (5) solved at 4.24-Å resolutions as a starting point for further refinements. Due to the poor density map resolution, the atomic coordinates for a number of amino acid residues of the closed TRPA1 structure were not determined (SI Appendix, Fig. S2 ). Thus, by using a procedure similar to what we implemented previously (6), we built all missing loops and linkers, and we optimized the conformations of all side chains. To fill the unresolved sequence ranges of TRPA1, we used the structure of the structural analog TRPV1 (5irx.pdb) (7), solved by cryo-EM at 2.95 Å resolution.
We used the sequence alignment (TRPA1 UniProt code: O75762) as input for Modeller (v. 9.16) (8), to generate an initial set of 6032 refined structures of the full length, closed TRPA1. Then, we selected the top refined structure by combining the DOPE score (8) and clustering (using the Jarvis Patrick method), and we subsequently performed side chain optimization using SCWRL4 (Fig. 4) 
(9).
Open TRPA1 (Model- Fig. S13 ), have an RMSD of 2.2 Å, a value that is comparable to the uncertainties associated with experimental structures solved in the 4-Å range (a typical value for cryo-EM structures).
We isolated the transmembrane (TM) segment of TRPV1 (5irx.pdb), as template for generating several homology models of the open TRPA1 channel (residues 701 to 991). We then used the sequence alignment to generate 500 initial structures. We restrained residues 917 to 929 to adopt helical conformations that resemble the structure of the pore helix of TRPA1 (3j9p.pdb). Similar to the case of closed TRPA1, we selected the final model by combining clustering, DOPE score and visual inspection before optimizing all side chains by SCWRL4 (Fig. 4) .
Open and Closed TRPA1 on TRPV6 (Model-2 and Model-3): We generated an independent set of TRPA1 models in the open and closed states using the experimental structures of TRPV6 as the templates (6BO8 and 6BOA) (26) . In particular, we modeled open and closed TRPA1 using the experimental as templates. Models were generated and validated using tools available at SwissModel server (https://swissmodel.expasy.org/).
Protein Structure Preparation
We prepared all structures of TRPA1 (open and closed states) for subsequent modeling by using the Protein Preparation Wizard procedure (11) . To allow relaxation of structures, we performed restrained minimizations using the impref utility by Impact, with OPLS2003 force field (12) . For convergence, we set an RMSD atom displacement threshold of 0.30 Å.
Binding Site Identification
We used SiteMap (13, 14) to search for sites suitable for ligand binding on open and closed TRPA1 structures (Fig. 5a, SI Appendix, Fig. S3 ). Sites were searched across the entire protein structures.
To define a site, a minimum of 15 site points was required using a less restrictive definition of hydrophobicity and with standard grid. Site maps were cropped at 4 Å from the nearest site point.
Ligand Preparation
We used molecular docking to predict binding modes of piperidine carboxamides (Scheme I and II), including PIPC1, PIPC2, and their inactive (S)-enantiomers PIPC3 and PIPC4. Additionally, we docked the TRPA1 antagonist ligand A-967079, which was solved in complex with TRPA1 in the closed state (5) , as well as a number of general anesthetics (6, 15 
Binding Modes Generation
We used molecular docking to generate binding modes of ligands against TRPA1 (closed and open structures), including A-967079, several piperidine carboxamides (PIPCs) (Scheme I and II) and general anesthetics (6, 15) . We performed calculations at two levels: (i) rigid receptor docking, by
Glide with SP and XP scoring functions (19, 20) ; (ii) flexible receptor docking, by Induced fit (IDF) (21) . First, we run independent jobs with different settings, including centering the grid on locations of A-967079 (5), propofol (15) and general anesthetics (6), or by using results from SiteMap (13, 14) . We then used literature data (3) and our own SAR explorations (Scheme I and II) to guide the selection of our initial binding hypotheses, further refined by IFD. Final poses were selected upon consensus of results by multiple settings, by cluster analyses and by prioritizing top ranking poses in most populated clusters and those in agreement with SAR. We also performed additional sets of docking calculations of PIPC1 to PIPC4 against TRPA1 mutant structures and compared the results with SAR and experimental mutagenesis studies.
Delta Affinity Calculations
We performed residue mutations of TRPA1 in open and closed states (all four models) and compared the relative PIPC1 binding affinities with the changes in EC50 (fold change) in experimental mutagenesis studies (SI Appendix, Table S1 ).
Classical molecular dynamics simulation
We performed classical, all atom molecular dynamics simulation of the TRPA1 channel in the closed state. The starting configuration was taken from our refined model of closed TRPA1, as described in the dedicated paragraph. We embed the protein in a bilayer of 1-palmitoyl2oleoylphosphatidylcholine (POPC); we then hydrated and neutralized the system by adding 150 mM NaCl solution. Overall, our final system comprised ~ 415,000 atoms, with a size of 160x160x180 Å 3 . While we used the CHARMM36 force field to describe protein and lipid atoms, we used TIP3P model for water molecules (22) . We ran our simulation through a multistep protocol. First, we performed energy minimization of the system. Then, upon setting harmonic potentials on protein backbone and side-chain atoms as well as on lipid head groups, we applied position restraints that were gradually released during the first 50-ns simulation time. Specifically, an initial force constant K1 = 20 kcal/mol/Å 2 was applied to all restrained atoms. Finally, we performed an additional 405-ns production run of unrestrained dynamics. During our simulation, the velocity Verlet integration method was used to solve the equations of motion, implementing a time step of 2 fs, for a total of 415 ns simulation. The Particle mesh Ewald (PME) method was used to solve the electrostatic potential. The Langevin temperature and Langevin piston coupling schemes were applied. The systems were run at 300 K temperature and 1 atm pressure. We used the programs VMD18 (23) (version 1.9) and NAMD (24) (version 2.12) for system preparation and trajectory analysis.
Data preparation, visualization and analyses
Modeller was used to perform homology modeling (https://salilab.org/modeller/). All side chains were optimized with SCWRL (http://dunbrack.fccc.edu/scwrl4/). Protein preparation, ligand preparation, pKa predictions, binding site identification, molecular docking and delta affinity predictions were all performed using computational tools distributed by Schrödinger, LLC, New
York, NY (https://www.schrodinger.com/). Molecular sketches and additional pKa predictions were obtained using ChemAxon (https://docs.chemaxon.com/). Graphics and visual analyses were obtained using VMD (http://www.ks.uiuc.edu/Research/vmd/) and Maestro (Schrödinger).
Fig. S1
. Optimization of the cryo-EM structure of TRPA1 (closed state) by computational modeling. In a, the cryo-EM structure is shown (PDB-ID: 3J9P.pdb) (25) , rendered as new cartoon in green color. In b, c superimposition of the experimental structure (green) and the model (blue) are shown. In b, a single TRPA1 subunit is shown; unresolved amino-acid ranges are shown as red dots. d-e: superimposition of TRPA1 models; f-g: superimposition of TRPV6 experimental structures (26) used as templates for homology modeling. In d, TRPA1 model built on the TRPV1 template (Model-1) and the refined experimental structure of TRPA1 (Refined) are rendered as new cartoons in red and blue. In e, TRPA1 model built on TRPV6 as template (Model-2) and the refined experimental structure of TRPA1 (Refined) are rendered as new cartoons in cyan and blue.
In f, open and closed structures of TRPV6 are rendered as new cartoons in pink and yellow. In g, superimposition of S6 helices in TRPV6 structures highlights the experimentally observed movement of S6, associated with the conserved p-bulge rearrangement. Residues involved in the p-bulge rearrangement are represented by Ca atoms and rendered as spheres. Rendering as in Supplementary Fig. 7 . This binding mode is not in agreement with experiments (SAR changes). Residues in blue were confirmed with mutagenesis data (Table S1) Table S4 . Experimentally determined pKa value and percentage of compounds in neutral form at pH7. 4 . pKa values were determined using UV-metric as described previously (27) . Step 2
Supplementary Tables
Residue#
A mixture of ethyl 4-(4-fluorophenyl)-3-oxobutanoate (645 mg, 2.88 mmol) and ammonium acetate (1.11 g, 14.4 mmol) in ethanol (5 mL) was heated at reflux for 2.5 h. The cooled mixture was concentrated under vacuum and re-dissolved in acetic acid (5 mL). Sodium triacetoxyborohydride (1.81 g, 8.63 mmol) was added and the mixture stirred at room temperature for 2 h. The mixture was concentrated under vacuum, re-dissolved in ethyl acetate, washed with water, saturated aqueous NaHCO3 solution, brine, dried (Na2SO4), filtered and concentrated under vacuum. The residue was dissolved in diethyl ether, then HCl (2M in diethyl ether) was added.
The mixture was concentrated under vacuum to leave a yellow residue (964 mg, overweight). M/z 226 (M+H) + .
Step 3
To a mixture of ethyl 3-amino-4-(4-fluorophenyl)butanoate (2.88 mmol) and potassium carbonate (59 mg, 0.43 mmol) in methanol (10 mL) at reflux was added a solution of 1-ethyl-1-methyl piperidin-1-ium iodide (2.3 g, 8.6 mmol) in water (1.5 mL), and the mixture stirred at reflux for 2.5 h. The cooled solution was concentrated under vacuum to remove the organic solvent, then ethyl acetate and water were added. The organics were washed with brine, dried (Na2SO4), filtered and concentrated under vacuum. Flash chromatography (0-100% ethyl acetate in isohexane) gave a yellow residue (394 mg, 44%, two steps). M/z 308 (M+H) + .
Step 4
To a mixture of ethyl 4-(4-fluorophenyl)-3-(4-oxo-1-piperidinyl)butanoate (390 mg, 1.27 mmol) and cesium fluoride (0.13 mmol) in tetrahydrofuran (10 mL) at 10 °C was added (trifluoromethyl)trimethylsilane (1.03 g, 7.23 mmol) dropwise, then the mixture allowed to warm to room temperature with stirring over 16 h. Aqueous HCl solution (1M, 5 mL) was added and the mixture stirred at room temperature for 1 h. The solution was basified with K2CO3, then extracted with ethyl acetate (×2). The combined extracts were washed with brine, dried (Na2SO4), filtered and concentrated under vacuum. Flash chromatography (0-50% ethyl acetate in isohexane) gave a yellow residue (306 mg, 64%). M/z 378 (M+H) + .
Step 
